CROSBY Research – Xiabuxiabu (520 HK/BUY): FY23 net loss narrowed on higher revenue and GPM
05 Apr 2024 Xiabu’s FY23 revenue was up by 25.3% YoY to Rmb5,918m, mainly driven...
CROSBY Research – China Suntien Green Energy (956 HK/BUY): Increasing capex in FY24
02 Apr 2024 FY23 revenue was up by 9.3% YoY to Rmb20.3bn, mainly due to...
CROSBY Research – Anta Sports (2020 HK/BUY): FY23 NP up by 35% YoY, better than expected
28 Mar 2024 Anta’s FY23 revenue was up by 16.2% YoY to Rmb62.36bn driven by...
CROSBY Research – Canvest Environmental (1381 HK/BUY): Topline down 40% on fewer construction projects
27 Mar 2024 FY23 revenue decreased by 39.6% YoY to HK$4.98bn, mainly due to 1)...
CROSBY Research – Natural Food International (1837 HK/BUY): Better than expected FY23 results
27 Mar 2024 NFI’s FY23 topline was up by 7% YoY to Rmb1,845m. Offline sales...
CROSBY Research – Q-Tech (1478 HK/BUY): Revenue growth turned around and GPM bottomed out in 2H23; expect product mix improvement persist into FY24
27 Mar 2024 After three consecutive declines of its semi-annual revenue, Q-Tech reported a turnaround...
CROSBY Research – WL Delicious (9985 HK): Expects a >15% YoY sales growth in FY24
25 Mar 2024 WL Delicious ‘s FY23 revenue increased by 5.2% YoY to Rmb4.87bn. Offline...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 55)
25 Mar 2024 According to Reuters, China has introduced guidelines to phase out US microprocessors...
CROSBY Research – Sunny Optical (2382 HK/BUY): Conservative HLS/ HCM shipment and GPM guidance, but product mix improvement may be upside surprise
25 Mar 2024 After four consecutive declines of its semi-annual revenue, Sunny reported a turnaround...
CROSBY Research – Tai Hing (6811 HK): Turnaround in FY23 with a generous payout ratio
25 Mar 2024 Tai Hing’s FY23 revenue increased by 20.1% YoY to HK$3.21bn, with revenues...
CROSBY Research – Vincent Medical (1612 HK/BUY): Achieving financial turnaround in FY23
21 Mar 2024 Vincent Medical’s FY23 turnover (VM) amounted to HK$718.0m, representing a YoY increase...
CROSBY Research – Xiaomi Corporation (1810 HK): Solid 4Q23 core business recovery; launching of new EV will be near-term catalyst
21 Mar 2024 Xiaomi reported 4Q23 results, with its revenue up 10.9% YoY to Rmb73.2bn...
CROSBY Research – Xtep International (1368 HK/BUY): Inline FY23 results ; Saucony achieved profitability
19 Mar 2024 Xtep’s FY23 revenue was up by 10.9% YoY to Rmb14,346m, mainly driven...
CROSBY Research – China Lilang (1234 HK): Expects at least 15% retail sales growth in FY24
19 Mar 2024 The company reported a 14.8% YoY increase in topline to Rmb3,544m in...
CROSBY Research – Wasion Holdings (3393 HK/BUY): Strong FY23 NP growth on solid revenue growth and GPM improvement
18 Mar 2024 Following the positive profit alert issued in Feb, it is no surprise...
CROSBY Research – Giordano (709 HK): FY23 NP rose by 29% YoY on higher GPM and operating leverage
18 Mar 2024 FY23 revenue slightly increased by 1.9% YoY to HK$3,873m, mainly supported by...
CROSBY Research – 361 Degrees (1361 HK/BUY): Solid FY23 results with strong growth from Kids and online segments
14 Mar 2024 FY23 revenue was up 21.0% YoY to Rmb8.4bn, with core brand retail...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 54)
11 Mar 2024 (Bloomberg) Hong Kong’s 10 biggest residential estates saw transactions rise to the...
CROSBY Research – Concord (182 HK/BUY): Solid FY23 results
08 Mar 2024 CNE’s FY23 revenue was up by 7.8% YoY to Rmb2,589m (excluding the...
CROSBY Research – JNBY (3306 HK): Net profit increased by 55% YoY on better margins
01 Mar 2024 JNBY announced its FY1H24 interim results, with revenue increased by 26.1% YoY...